Welcome to LookChem.com Sign In|Join Free
  • or
1,1-Cyclopropanedicarboxamide, N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-phenylis a complex organic compound with a unique molecular structure. It is characterized by a cyclopropane ring connected to two carboxamide groups, with one of the phenyl rings substituted by a 6,7-dimethoxy-4-quinolinyloxy group. 1,1-Cyclopropanedicarboxamide,
N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-phenylhas potential applications in various fields due to its specific chemical properties.

849221-94-9

Post Buying Request

849221-94-9 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

849221-94-9 Usage

Uses

Used in Pharmaceutical Industry:
1,1-Cyclopropanedicarboxamide, N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-phenylis used as a kinase inhibitor for its ability to target and regulate the activity of specific kinase enzymes. Kinase inhibitors are important in the development of drugs for the treatment of various diseases, including cancer and other disorders related to abnormal cell signaling.

Check Digit Verification of cas no

The CAS Registry Mumber 849221-94-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,4,9,2,2 and 1 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 849221-94:
(8*8)+(7*4)+(6*9)+(5*2)+(4*2)+(3*1)+(2*9)+(1*4)=189
189 % 10 = 9
So 849221-94-9 is a valid CAS Registry Number.

849221-94-9Downstream Products

849221-94-9Relevant academic research and scientific papers

Preparation method of cabozantinib defluorination impurity

-

, (2020/08/25)

The invention discloses a preparation method of a cabozantinib defluorination impurity. The method comprises the following steps: preparing an intermediate 1, preparing 4-chloro-6, 7-dimethoxyquinoline, preparing an intermediate 2, and removing fluorine i

FUSED HETEROCYCLIC DERIVATIVES AND USE THEREOF

-

Page/Page column 220-221, (2010/01/29)

The present invention provides a fused heterocyclic derivative having a strong kinase inhibitory activity and use thereof. The present invention relates to a compound represented by the formula wherein each symbol is as defined in the present specificatio

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 849221-94-9